Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Phase IIa, multicenter, randomised, double-blind, placebo controlled study of the efficacy and safety of RO0506997, an α4 integrin antagonist, in combination with methotrexate, versus methotrexate alone, in patients with mild/moderate active rheumatoid arthritis (RA) who have had a partial response to a stable dose of methotrexate https://kusajili.com:443/Trial/eOA3_SHimU-rmmgDCmBE9A%24phase-iia-multicenter-randomised-double-blind-placebo-controlled-study-of-the-efficacy-and-safety-of-ro0506997-an-4-integrin-an
I have read and accept the terms of use of the site and the Privacy Policy
Send your message